SKI Market

Indian Indices

Sensex

84,929.36 447.55
( 0.53%)

Global Indices

Nasdaq

47,984.72 77.74
(0.16%)

Dow Jones

6,795.86 53.43
(0.79%)

Hang Seng

49,620.18 618.68
(1.26%)

Nikkei 225

9,823.75 49.43
(0.51%)

Forex

USD-INR

90.47 -0.43
(-0.47%)

EUR-INR

106.15 -0.72
(-0.68%)

GBP-INR

120.98 -0.85
(-0.70%)

JPY-INR

0.58 0.00
(-0.85%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Medicamen Organics Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

92885

INE0PE401018

24.7648718

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MEDIORG

8.57

28.08

EPS(TTM)

Face Value()

Div & Yield %

2.8

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	1333.90	1054.48	928.62	863.77	673.75	661.46
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1333.90	1054.48	928.62	863.77	673.75	661.46
Other Income	41.55	31.88	21.15	39.76	58.60	19.51
Stock Adjustments	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	1375.45	1086.36	949.77	903.53	732.35	680.97
EXPENDITURE :
Raw Materials	0.00	0.00	0.00	0.00	0.00	0.00
Power & Fuel Cost	12.12	10.96	9.46	7.14	5.76	7.66
Employee Cost	373.00	314.18	294.88	270.30	217.06	209.72
Other Manufacturing Expenses	240.54	181.30	158.72	150.38	140.28	143.65
Selling & Administrative Expenses	69.55	50.50	46.42	40.92	32.60	35.43
Miscellaneous Expenses	21.54	16.13	13.88	4.92	10.20	5.24
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	716.76	573.06	523.36	473.67	405.90	401.71
Operating Profit	658.68	513.30	426.41	429.86	326.45	279.26
Interest	7.16	6.87	6.67	6.62	7.06	8.05
Gross Profit	651.52	506.43	419.74	423.24	319.39	271.21
Depreciation	65.13	58.41	54.20	47.40	39.39	45.94
Profit Before Tax	586.39	448.02	365.54	375.84	280.00	225.27
Tax	146.23	112.23	89.48	87.01	63.10	58.26
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.86	-1.33	1.53	-0.59	-2.06	2.94
Reported Net Profit	441.02	337.12	274.54	289.41	218.97	164.07
Extraordinary Items	19.20	10.85	9.95	9.19	11.39	7.74
Adjusted Net Profit	421.82	326.27	264.59	280.22	207.58	156.33
Adjustment below Net Profit	-2.15	-1.31	0.00	0.00	0.00	0.00
P & L Balance brought forward	617.56	487.87	404.77	303.94	334.25	240.33
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	344.98	206.12	184.83	188.58	249.28	70.16
P & L Balance carried down	711.46	617.56	494.48	404.77	303.94	334.25
Dividend	0.00	0.00	0.00	0.00	0.00	70.16
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	725.00	465.00	377.50	387.50	629.40	121.80
Dividend Per Share(Rs)	72.50	46.50	37.75	38.75	62.94	12.18
Earnings Per Share-Unit Curr	89.22	68.60	56.04	59.18	44.88	33.65
Earnings Per Share(Adj)-Unit Curr	17.84	13.72	11.21	11.84	8.98	33.65
Book Value-Unit Curr	209.57	179.92	148.60	117.27	93.97	99.56
Book Value(Adj)-Unit Curr	41.91	35.98	29.72	23.45	18.79	99.56

84,929.36 447.55 ( 0.53%)

47,984.72 77.74 (0.16%)

6,795.86 53.43 (0.79%)

49,620.18 618.68 (1.26%)

9,823.75 49.43 (0.51%)

90.47 -0.43 (-0.47%)

106.15 -0.72 (-0.68%)

120.98 -0.85 (-0.70%)

0.58 0.00 (-0.85%)